Our findings are supported by the possibility that genetic polymorphisms in the IL-1β gene, which are linked to a higher risk of aggressive prostate cancer, are the causes of the different expression patterns of IL-1β and its receptors in PCa compared to normal prostate tissue [52]. This evidence concerns the gene IL1B and prostate carcinoma.